ArticleVonoprazan versus Conventional Proton Pump Inhibitors Based Regimens in Helicobacter Pylori Eradication Therapy
ArticleVonoprazan versus Conventional Proton Pump Inhibitors Based Regimens in Helicobacter Pylori Eradication Therapy
ArticleHelicobacter Pylori Treatment Eradication in Egypt: Standard Clarithromycin-based Triple versus Quadruple Regimen Therapy
ArticleHelicobacter Pylori Treatment Eradication in Egypt: Standard Clarithromycin-based Triple versus Quadruple Regimen Therapy
ArticleEffectiveness of 14-days course of clarithromycin-based triple therapy as first line therapy for h.pylori infection in egyptian elderly patients
ArticleEffectiveness of 14-days course of clarithromycin-based triple therapy as first line therapy for h.pylori infection in egyptian elderly patients
ArticleEffectiveness of Different Treatment Regimens on Eradication of Helicobacter Pylori Infection (A Single Center Experience in Kuwait)
ArticleEffectiveness of Different Treatment Regimens on Eradication of Helicobacter Pylori Infection (A Single Center Experience in Kuwait)
ArticleEfficacy of Adding Lactoferrin with Triple Therapy for Helicobacter Pylori Eradication in Egyptian Patients
ArticleEfficacy of Adding Lactoferrin with Triple Therapy for Helicobacter Pylori Eradication in Egyptian Patients
ArticleVONOPRAZAN VERSUS PROTON PUMP INHIBITORS IN COMBINATION WITH ANTIBIOTICS AS A TRIPLE THERAPY FOR ERADICATION OF CLARITHROMYCIN RESISTANT STRAIN OF HELICOBACTER PYLORI
ArticleVONOPRAZAN VERSUS PROTON PUMP INHIBITORS IN COMBINATION WITH ANTIBIOTICS AS A TRIPLE THERAPY FOR ERADICATION OF CLARITHROMYCIN RESISTANT STRAIN OF HELICOBACTER PYLORI
ArticleEMPIRICAL VERSUS SUSCEPTIBILITY-BASED ERADICATION THERAPY FOR HELICOBACTER PYLORI INFECTION IN EGYPT
ArticleEMPIRICAL VERSUS SUSCEPTIBILITY-BASED ERADICATION THERAPY FOR HELICOBACTER PYLORI INFECTION IN EGYPT
ArticleA New Sequential Regimen for Treatment of H. Pylori in Naïve and Previously Treated Patients with Traditional Triple Therapy
ArticleA New Sequential Regimen for Treatment of H. Pylori in Naïve and Previously Treated Patients with Traditional Triple Therapy
ArticleA Novel Three Drug Rigemen (Moxifloxacin –Omeprazole - Nitazoxanide) in Comparison to Traditional Triple Therapy for Treatment and Eradication of Naïve and Resistant H. Pylori Inf
ArticleA Novel Three Drug Rigemen (Moxifloxacin –Omeprazole - Nitazoxanide) in Comparison to Traditional Triple Therapy for Treatment and Eradication of Naïve and Resistant H. Pylori Inf
ArticleA NOVEL THREE DRUG RIGEMEN (MOXIFLOXACIN –OMEPRAZOLE - NITAZOXANIDE) IN COMPARISON TO TRADITIONAL TRIPLE THERAPY FOR TREATMENT AND ERADICATION OF NAÏVE AND RESISTANT H.PYLORI INFE
ArticleA NOVEL THREE DRUG RIGEMEN (MOXIFLOXACIN –OMEPRAZOLE - NITAZOXANIDE) IN COMPARISON TO TRADITIONAL TRIPLE THERAPY FOR TREATMENT AND ERADICATION OF NAÏVE AND RESISTANT H.PYLORI INFE